share_log

双鹭药业(002038.SZ)董事梁淑洁拟减持不超50.02万股

Director Liang Shujie of Beijing SL Pharmaceutical (002038.SZ) plans to reduce her shareholding by no more than 500,200 shares.

Zhitong Finance ·  Jun 24 09:59

Beijing SL Pharmaceutical (002038.SZ) announced that Liang Shujie, director and board secretary of the company, plans to reduce his shareholding by centralized bidding trading from July 16, 2024, to October 15, 2024.

According to the announcement made by Beijing SL Pharmaceutical (002038.SZ), Liang Shujie, director and board secretary of the company, plans to reduce his shareholding by no more than 500,200 shares through centralized bidding trading from July 16, 2024, to October 15, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment